Found 7 matching trials
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
PHASE3This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Tirzepatide for Obesity and Meth Use Disorder
PHASE2This is an open-label pilot study to evaluate the feasibility and prelimina...
Status
Active Not Recruiting
Location
UT Southwestern Medical Center
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
PHASE1This study will evaluate the behavioral effects of methamphetamine during m...
Location
University of Kentucky
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
PHASE1Naltrexone (NTX), an opioid receptor antagonist, has a longstanding history...
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
EARLY_PHASE1The research proposed in this application will determine the initial effica...
Location
University of Kentucky Medical Center
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
PHASE1The aim of this 2-stage, 3-site study is to investigate the effectiveness a...
Location
UCLA Integrated Substance Abuse Programs
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
PHASE3The primary objective of this study is to evaluate the efficacy of extended...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences